Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link

Cell Cycle

Volumn 13, Issue 6, 2014, Pages 890-897

  Cheng, Zhiyong ^a   Almeida, Fabio A ^a  

^a Fralin Life Science Institute   (United States)

Author keywords

Epigenetic; Lifestyle; Mitochondrial alteration; Obesity; Type 2 diabetes

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME C OXIDASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; MICRORNA; MICRORNA 15A; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MYOCYTE ENHANCER FACTOR 2; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2;

3' UNTRANSLATED REGION; AEROBIC METABOLISM; ALCOHOL CONSUMPTION; BIOGENESIS; BODY MASS; CALORIC RESTRICTION; CHROMATIN STRUCTURE; DIET; DNA METHYLATION; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; EPIGENETICS; EXOCYTOSIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LIFESTYLE MODIFICATION; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; OBESITY; OXIDATIVE PHOSPHORYLATION; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; REVIEW; SOCIAL STATUS; THERMOGENESIS; TRANSCRIPTION INITIATION; UPREGULATION;

EPIGENETIC; LIFESTYLE; MITOCHONDRIAL ALTERATION; OBESITY; TYPE 2 DIABETES;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; EPIGENESIS, GENETIC; HUMANS; LIFE STYLE; MITOCHONDRIA; MITOCHONDRIAL TURNOVER; OBESITY;

EID: 84897975266     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28189     Document Type: Review

References (82)

1. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56:2655-67; PMID:17827399; http://dx.doi.org/10.2337/ db07-0882
2. Fisher-Wellman KH, Neufer PD. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol Metab 2012; 23:142-53; PMID:22305519; http://dx.doi.org/10.1016/j.tem.2011.12.008
3. Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 2006; 75:367-401; PMID:16756496; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142512
4. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7:45-56; PMID:18177724; http://dx.doi.org/10.1016/j.cmet.2007.10.013
5. Muoio DM, Neufer PD. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 2012; 15:595-605; PMID:22560212; http://dx.doi.org/10.1016/j.cmet.2012.04.010
6. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 2006; 103:2653-8; PMID:16477035; http://dx.doi.org/10.1073/pnas.0511154103
7. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307:384-7; PMID:15662004; http://dx.doi.org/10.1126/science. 1104343
8. Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 2010; 21:589-98; PMID:20638297; http://dx.doi.org/10.1016/j.tem.2010.06.005
9. Cheng Z, Ristow M. Mitochondria and metabolic homeostasis. Antioxid Redox Signal 2013; 19:240-2; PMID:23432475; http://dx.doi.org/10.1089/ars.2013.5255
10. Gianotti TF, Sookoian S, Dieuzeide G, García SI, Gemma C, González CD, Pirola CJ. A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring) 2008; 16:1591-5; PMID:18451773; http://dx.doi.org/10.1038/oby.2008.253
11. Cheng Z, White MF. Foxo1 in hepatic lipid metabolism. Cell Cycle 2010; 9:219-20; PMID:20023377; http://dx.doi.org/10.4161/cc.9.2.10567
12. Pirola CJ, Gianotti TF, Burgueño AL, Rey-Funes M, Loidl CF, Mallardi P, Martino JS, Castaño GO, Sookoian S. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2013; 62:1356-63; PMID:22879518; http://dx.doi.org/10.1136/gutjnl-2012-302962
13. Sookoian S, Rosselli MS, Gemma C, Burgueño AL, Fernández Gianotti T, Castaño GO, Pirola CJ. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 2010; 52:1992-2000; PMID:20890895; http://dx.doi.org/10. 1002/hep.23927
14. Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT, Depinho RA, Puigserver P, White MF. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 2009; 15:1307-11; PMID:19838201; http://dx.doi.org/10.1038/nm.2049
15. Sleigh A, Raymond-Barker P, Thackray K, Porter D, Hatunic M, Vottero A, Burren C, Mitchell C, McIntyre M, Brage S, et al. Mitochondrial dysfunction in patients with primary congenital insulin resistance. J Clin Invest 2011; 121:2457-61; PMID:21555852; http://dx.doi.org/10.1172/JCI46405
16. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 2008; 118:789-800; PMID:18188455
17. Sadagurski M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, Krainc D, White MF. IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest 2011; 121:4070-81; PMID:21926467; http://dx.doi.org/10.1172/JCI46305
18. Maechler P. Mitochondrial function and insulin secretion. Mol Cell Endocrinol 2013; 379:12-8; PMID:23792187; http://dx.doi.org/10.1016/j.mce.2013. 06.019
19. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001; 414:807-12; PMID:11742413; http://dx.doi.org/10.1038/ 414807a
20. Martin-Montalvo A, de Cabo R. Mitochondrial metabolic reprogramming induced by calorie restriction. Antioxid Redox Signal 2013; 19:310-20; PMID:22901095; http://dx.doi.org/10.1089/ars.2012.4866
21. Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2012; 8:92-103; PMID:21912398; http://dx.doi.org/10.1038/nrendo.2011.138
22. Toledo FG, Goodpaster BH. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging. Mol Cell Endocrinol 2013; 379:30-4; PMID:23792186; http://dx.doi.org/10. 1016/j.mce.2013.06.018
23. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009; 10:189-98; PMID:19723495; http://dx.doi.org/10.1016/j.cmet.2009.07.011
24. Gemma C, Sookoian S, Alvariñas J, García SI, Quintana L, Kanevsky D, González CD, Pirola CJ. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009; 17:1032-9; PMID:19148128; http://dx.doi.org/10.1038/oby. 2008.605
25. Ribel-Madsen R, Fraga MF, Jacobsen S, Bork-Jensen J, Lara E, Calvanese V, Fernandez AF, Friedrichsen M, Vind BF, Højlund K, et al. Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One 2012; 7:e51302; PMID:23251491; http://dx.doi.org/10.1371/journal.pone.0051302
26. Gemma C, Sookoian S, Dieuzeide G, García SI, Gianotti TF, González CD, Pirola CJ. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab 2010; 100:83-7; PMID:20202876; http://dx.doi.org/10.1016/j.ymgme. 2010.02.004
27. Zhang Y, Yang L, Gao YF, Fan ZM, Cai XY, Liu MY, Guo XR, Gao CL, Xia ZK. microRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Mol Cell Endocrinol 2013; 381:230-40; PMID:23954742; http://dx.doi.org/10.1016/j.mce.2013.08.004
28. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008; 51:615-22; PMID:18270681; http://dx.doi.org/10.1007/s00125-007-0916-5
29. Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci USA 2011; 108:3630-5; PMID:21321201; http://dx.doi.org/10.1073/pnas.1012311108
30. Sripada L, Tomar D, Prajapati P, Singh R, Singh AK, Singh R. Systematic analysis of small RNAs associated with human mitochondria by deep sequencing: detailed analysis of mitochondrial associated miRNA. PLoS One 2012; 7:e44873; PMID:22984580; http://dx.doi.org/10.1371/journal.pone.0044873
31. Bandiera S, Matégot R, Girard M, Demongeot J, Henrion-Caude A. MitomiRs delineating the intracellular localization of microRNAs at mitochondria. Free Radic Biol Med 2013; 64:12-9; PMID:23792138; http://dx.doi.org/10.1016/j.freeradbiomed.2013.06.013
32. De Pauw A, Tejerina S, Raes M, Keijer J, Arnould T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 2009; 175:927-39; PMID:19700756; http://dx.doi.org/10. 2353/ajpath.2009.081155
33. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell 2012; 148:1145-59; PMID:22424226; http://dx.doi.org/10.1016/j.cell.2012.02.035
34. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007; 56:2085-92; PMID:17519422; http://dx.doi.org/10.2337/db07-0093
35. López-Lluch G, Hunt N, Jones B, Zhu M, Jamieson H, Hilmer S, Cascajo MV, Allard J, Ingram DK, Navas P, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci USA 2006; 103:1768-73; PMID:16446459; http://dx.doi.org/10.1073/pnas.0510452103
36. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012; 148:421-33; PMID:22304913; http://dx.doi.org/10.1016/j.cell.2012.01.017
37. Cheng Z, Schmelz EM, Liu D, Hulver MW. Targeting mitochondrial alterations to prevent type 2 diabetes - Evidence from studies of dietary redox active compounds. Mol Nutr Food Res 2014; http://dx.doi.org/10.1002/mnfr. 201300747
38. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006; 27:728-35; PMID:17018837; http://dx.doi.org/10.1210/er.2006-0037
39. Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 2012; 46:265-87; PMID:22934639; http://dx.doi.org/10.1146/annurev-genet-110410-132529
40. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 2005; 54:2685-93; PMID:16123358; http://dx.doi.org/10.2337/diabetes.54.9.2685
41. Hernández-Alvarez MI, Thabit H, Burns N, Shah S, Brema I, Hatunic M, Finucane F, Liesa M, Chiellini C, Naon D, et al. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1alpha/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 2010; 33:645-51; PMID:20032281; http://dx.doi.org/10.2337/dc09- 1305
42. Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, Godio C, Cermenati G, Gualerzi A, Donetti E, Rotili D, et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 2013; 62:732-42; PMID:23069623; http://dx.doi.org/10.2337/db12-0548
43. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. microRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011; 91:94-100; PMID:21146880; http://dx.doi.org/10. 1016/j.diabres.2010.11.006
44. Chen X, Wang K, Chen J, Guo J, Yin Y, Cai X, Guo X, Wang G, Yang R, Zhu L, et al. In vitro evidence suggests that miR-133a-mediated regulation of uncoupling protein 2 (UCP2) is an indispensable step in myogenic differentiation. J Biol Chem 2009; 284:5362-9; PMID:19073597; http://dx.doi.org/10.1074/jbc.M807523200
45. Rönn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P, Tuomi T, Isomaa B, Groop L, Vaag A, et al. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 2008; 51:1159-68; PMID:18488190; http://dx.doi.org/10.1007/s00125-008-1018-8
46. Ling C, Poulsen P, Carlsson E, Ridderstråle M, Almgren P, Wojtaszewski J, Beck-Nielsen H, Groop L, Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J Clin Invest 2004; 114:1518-26; PMID:15546003; http://dx.doi.org/10.1172/JCI21889
47. Edwards TL, Velez Edwards DR, Villegas R, Cohen SS, Buchowski MS, Fowke JH, Schlundt D, Long J, Cai Q, Zheng W, et al. HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes. Am J Epidemiol 2012; 175:11-21; PMID:22106445; http://dx.doi.org/10.1093/aje/kwr272
48. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci USA 2003; 100:7111-6; PMID:12764228; http://dx.doi.org/10.1073/pnas.1232352100
49. Grégoire S, Xiao L, Nie J, Zhang X, Xu M, Li J, Wong J, Seto E, Yang XJ. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol 2007; 27:1280-95; PMID:17158926; http://dx.doi.org/10. 1128/MCB.00882-06
50. Brøns C, Jacobsen S, Nilsson E, Rönn T, Jensen CB, Storgaard H, Poulsen P, Groop L, Ling C, Astrup A, et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 2010; 95:3048-56; PMID:20410232; http://dx.doi.org/10.1210/jc.2009-2413
51. Leigh-Brown S, Enriquez JA, Odom DT. Nuclear transcription factors in mammalian mitochondria. Genome Biol 2010; 11:215; PMID:20670382; http://dx.doi.org/10.1186/gb-2010-11-7-215
52. Choi YS, Kim S, Pak YK. Mitochondrial transcription factor A (mtTFA) and diabetes. Diabetes Res Clin Pract 2001; 54(Suppl 2):S3-9; PMID:11733104; http://dx.doi.org/10.1016/S0168-8227(01)00330-8
53. Hernandez-Mijares A, Rocha M, Apostolova N, Borras C, Jover A, Bañuls C, Sola E, Victor VM. Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients. Free Radic Biol Med 2011; 50:1215-21; PMID:21262346; http://dx.doi.org/10.1016/j.freeradbiomed.2011.01.019
54. Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 2001; 50:1302-10; PMID:11375330; http://dx.doi.org/10.2337/diabetes.50.6.1302
55. Chan CB, Saleh MC, Koshkin V, Wheeler MB. Uncoupling protein 2 and islet function. Diabetes 2004; 53(Suppl 1):S136-42; PMID:14749279; http://dx.doi.org/10.2337/diabetes.53.2007.S136
56. Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006; 4:e31; PMID:16366736; http://dx.doi.org/10.1371/journal.pbio.0040031
57. Bolmeson C, Esguerra JL, Salehi A, Speidel D, Eliasson L, Cilio CM. Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. Biochem Biophys Res Commun 2011; 404:16-22; PMID:21094635; http://dx.doi.org/10.1016/j.bbrc.2010.11.024
58. Morita S, Horii T, Kimura M, Hatada I. MiR-184 regulates insulin secretion through repression of Slc25a22. PeerJ 2013; 1:e162; PMID:24109547; http://dx.doi.org/10.7717/peerj.162
59. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 2010; 31:364-95; PMID:20156986; http://dx.doi.org/10. 1210/er.2009-0027
60. Ling C, Poulsen P, Simonsson S, Rönn T, Holmkvist J, Almgren P, Hagert P, Nilsson E, Mabey AG, Nilsson P, et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest 2007; 117:3427-35; PMID:17948130; http://dx.doi.org/10.1172/JCI30938
61. Gallagher IJ, Scheele C, Keller P, Nielsen AR, Remenyi J, Fischer CP, Roder K, Babraj J, Wahlestedt C, Hutvagner G, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010; 2:9; PMID:20353613; http://dx.doi.org/10. 1186/gm130
62. Chen GQ, Lian WJ, Wang GM, Wang S, Yang YQ, Zhao ZW. Altered microRNA expression in skeletal muscle results from high-fat diet-induced insulin resistance in mice. Mol Med Rep 2012; 5:1362-8; PMID:22395471
63. Baseler WA, Thapa D, Jagannathan R, Dabkowski ER, Croston TL, Hollander JM. miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. Am J Physiol Cell Physiol 2012; 303:C1244-51; PMID:23034391; http://dx.doi.org/10.1152/ajpcell.00137.2012
64. Magenta A, Greco S, Gaetano C, Martelli F. Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci 2013; 14:17319-46; PMID:23975169; http://dx.doi.org/10.3390/ijms140917319
65. Yildirim SS, Akman D, Catalucci D, Turan B. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 2013; 67:1397-408; PMID:23723006; http://dx.doi.org/10.1007/s12013-013- 9672-y
66. Kowluru RA. Mitochondria damage in the pathogenesis of diabetic retinopathy and in the metabolic memory associated with its continued progression. Curr Med Chem 2013; 20:3226-33; PMID:23745551; http://dx.doi.org/ 10.2174/09298673113209990029
67. Aroor AR, Mandavia C, Ren J, Sowers JR, Pulakat L. Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome. Cardiorenal Med 2012; 2:87-109; PMID:22619657; http://dx.doi.org/10.1159/000335675
68. Subramanyam MA, Diez-Roux AV, Pilsner JR, Villamor E, Donohue KM, Liu Y, Jenny NS. Social factors and leukocyte DNA methylation of repetitive sequences: the multi-ethnic study of atherosclerosis. PLoS One 2013; 8:e54018; PMID:23320117; http://dx.doi.org/10.1371/journal.pone.0054018
69. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, Vishwanatha JK, Morabia A, Santella RM. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011; 6:293-9; PMID:21178401; http://dx.doi.org/10.4161/epi.6.3.14378
70. Zhang FF, Morabia A, Carroll J, Gonzalez K, Fulda K, Kaur M, Vishwanatha JK, Santella RM, Cardarelli R. Dietary patterns are associated with levels of global genomic DNA methylation in a cancer-free population. J Nutr 2011; 141:1165-71; PMID:21525250; http://dx.doi.org/10.3945/jn.110.134536
71. Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O'Gorman DJ, Zierath JR. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 2012; 15:405-11; PMID:22405075; http://dx.doi.org/10.1016/j.cmet.2012.01.001
72. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A. White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012; 7:606-14; PMID:22531363; http://dx.doi.org/10.4161/epi.20236
73. Perng W, Rozek LS, Mora-Plazas M, Duchin O, Marin C, Forero Y, Baylin A, Villamor E. Micronutrient status and global DNA methylation in school-age children. Epigenetics 2012; 7:1133-41; PMID:22918385; http://dx.doi.org/10.4161/ epi.21915
74. Nitert MD, Dayeh T, Volkov P, Elgzyri T, Hall E, Nilsson E, Yang BT, Lang S, Parikh H, Wessman Y, et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 2012; 61:3322-32; PMID:23028138; http://dx.doi.org/10. 2337/db11-1653
75. Iversen N, Krustrup P, Rasmussen HN, Rasmussen UF, Saltin B, Pilegaard H. Mitochondrial biogenesis and angiogenesis in skeletal muscle of the elderly. Exp Gerontol 2011; 46:670-8; PMID:21504786
76. Alibegovic AC, Sonne MP, Højbjerre L, Bork-Jensen J, Jacobsen S, Nilsson E, Faerch K, Hiscock N, Mortensen B, Friedrichsen M, et al. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab 2010; 299:E752-63; PMID:20739510; http://dx.doi.org/10.1152/ajpendo. 00590.2009
77. Abete I, Parra D, Martinez JA. Legume-, fish-, or high-protein-based hypocaloric diets: effects on weight loss and mitochondrial oxidation in obese men. J Med Food 2009; 12:100-8; PMID:19298202; http://dx.doi.org/10.1089/jmf. 2007.0700
78. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012; 308:2489-96; PMID:23288372; http://dx.doi.org/10.1001/ jama.2012.67929
79. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012; 379:2243-51; PMID:22683134; http://dx.doi.org/10.1016/S0140-6736(12)60525-X
80. Smith-Ray RL, Almeida FA, Bajaj J, Foland S, Gilson M, Heikkinen S, Seagle H, Estabrooks PA. Translating efficacious behavioral principles for diabetes prevention into practice. Health Promot Pract 2009; 10:58-66; PMID:17494949; http://dx.doi.org/10.1177/1524839906293397
81. Almeida FA, Shetterly S, Smith-Ray RL, Estabrooks PA. Reach and effectiveness of a weight loss intervention in patients with prediabetes in Colorado. Prev Chronic Dis 2010; 7:A103; PMID:20712930
82. Estabrooks PA, Glasgow RE, Xu S, Dzewaltowski DA, Lee RE, Thomas D, Almeida FA, Thayer AN, Smith-Ray RL. Building a multiple modality, theory-based physical activity intervention: The development of CardiACTION! Psychol Sport Exerc 2011; 12:46-53; PMID:22473308; http://dx.doi.org/10.1016/j.psychsport. 2010.04.012